The global mycoplasma testing kits and reagents market is expected to grow at a CAGR of 5.5% during the forecast period, to reach USD 1.2 billion by 2030. The growth of this market is driven by the increasing demand for mycoplasma testing kits and reagents in various applications such as academic research institutes, cell banks, contract research organizations, pharmaceutical & biotechnology companies.
PCR assays are expected to be the fastest-growing segment in the global mycoplasma testing kits and reagents market during the forecast period owing to their high accuracy and specificity in detecting Mycoplasma species from clinical samples. The nucleic acid detection kits segment is also projected to grow at a significant rate due to their ability in detecting Mycoplasma species from clinical samples with high sensitivity and specificity.
Some Of The Growth Factors Of This Market:
- The increasing prevalence of mycoplasma infections in humans and animals is one of the major factors driving the growth of this market.
- The increasing demand for animal products such as meat, milk, and eggs is also driving the growth of this market due to increased risk for mycoplasma infection in these animals which can be transmitted to humans through consumption or contact with infected animals or their products.
- Increasing awareness about mycoplasma infections among people and veterinarians will also drive the growth of this market.
- Increasing research on new drugs against mycoplasmosis will also drive the growth of this market.
Industry Growth Insights published a new data on “Mycoplasma Testing Kits & Reagents Market”. The research report is titled “Mycoplasma Testing Kits & Reagents Market research by Types (PCR Assays, Nucleic Acid Detection Kits, Stains, Elimination Kits, Standards & Controls, Others), By Applications (Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others), By Players/Companies Thermo Fisher Scientific, Merck KGaA, Lonza Group Ltd., PromoCell GmbH, ATCC (American Type Culture Collection), Charles River Laboratories International, Inc., Bionique Testing Laboratories, Inc., Biological Industries Israel Beit Haemek Ltd., InvivoGen”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Mycoplasma Testing Kits & Reagents Market Research Report
By Type
PCR Assays, Nucleic Acid Detection Kits, Stains, Elimination Kits, Standards & Controls, Others
By Application
Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others
By Companies
Thermo Fisher Scientific, Merck KGaA, Lonza Group Ltd., PromoCell GmbH, ATCC (American Type Culture Collection), Charles River Laboratories International, Inc., Bionique Testing Laboratories, Inc., Biological Industries Israel Beit Haemek Ltd., InvivoGen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Mycoplasma Testing Kits & Reagents Market Report Segments:
The global Mycoplasma Testing Kits & Reagents market is segmented on the basis of:
Types
PCR Assays, Nucleic Acid Detection Kits, Stains, Elimination Kits, Standards & Controls, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic Research Institutes, Cell Banks, Contract Research Organizations, Pharmaceutical & Biotechnology Companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- Merck KGaA
- Lonza Group Ltd.
- PromoCell GmbH
- ATCC (American Type Culture Collection)
- Charles River Laboratories International, Inc.
- Bionique Testing Laboratories, Inc.
- Biological Industries Israel Beit Haemek Ltd.
- InvivoGen
Highlights of The Mycoplasma Testing Kits & Reagents Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PCR Assays
- Nucleic Acid Detection Kits
- Stains
- Elimination Kits
- Standards & Controls
- Others
- By Application:
- Academic Research Institutes
- Cell Banks
- Contract Research Organizations
- Pharmaceutical & Biotechnology Companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Mycoplasma Testing Kits & Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Mycoplasma testing kits and reagents are used to detect the presence of Mycoplasma in a sample.
Some of the major companies in the mycoplasma testing kits & reagents market are Thermo Fisher Scientific, Merck KGaA, Lonza Group Ltd., PromoCell GmbH, ATCC (American Type Culture Collection), Charles River Laboratories International, Inc., Bionique Testing Laboratories, Inc., Biological Industries Israel Beit Haemek Ltd., InvivoGen.
The mycoplasma testing kits & reagents market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Mycoplasma Testing Kits & Reagents Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Mycoplasma Testing Kits & Reagents Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Mycoplasma Testing Kits & Reagents Market - Supply Chain
4.5. Global Mycoplasma Testing Kits & Reagents Market Forecast
4.5.1. Mycoplasma Testing Kits & Reagents Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Mycoplasma Testing Kits & Reagents Market Size (000 Units) and Y-o-Y Growth
4.5.3. Mycoplasma Testing Kits & Reagents Market Absolute $ Opportunity
5. Global Mycoplasma Testing Kits & Reagents Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Type
5.3.1. PCR Assays
5.3.2. Nucleic Acid Detection Kits
5.3.3. Stains
5.3.4. Elimination Kits
5.3.5. Standards & Controls
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Mycoplasma Testing Kits & Reagents Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Application
6.3.1. Academic Research Institutes
6.3.2. Cell Banks
6.3.3. Contract Research Organizations
6.3.4. Pharmaceutical & Biotechnology Companies
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Mycoplasma Testing Kits & Reagents Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Mycoplasma Testing Kits & Reagents Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Mycoplasma Testing Kits & Reagents Demand Share Forecast, 2019-2026
9. North America Mycoplasma Testing Kits & Reagents Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Application
9.4.1. Academic Research Institutes
9.4.2. Cell Banks
9.4.3. Contract Research Organizations
9.4.4. Pharmaceutical & Biotechnology Companies
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Type
9.7.1. PCR Assays
9.7.2. Nucleic Acid Detection Kits
9.7.3. Stains
9.7.4. Elimination Kits
9.7.5. Standards & Controls
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Mycoplasma Testing Kits & Reagents Demand Share Forecast, 2019-2026
10. Latin America Mycoplasma Testing Kits & Reagents Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Application
10.4.1. Academic Research Institutes
10.4.2. Cell Banks
10.4.3. Contract Research Organizations
10.4.4. Pharmaceutical & Biotechnology Companies
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Type
10.7.1. PCR Assays
10.7.2. Nucleic Acid Detection Kits
10.7.3. Stains
10.7.4. Elimination Kits
10.7.5. Standards & Controls
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Mycoplasma Testing Kits & Reagents Demand Share Forecast, 2019-2026
11. Europe Mycoplasma Testing Kits & Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Application
11.4.1. Academic Research Institutes
11.4.2. Cell Banks
11.4.3. Contract Research Organizations
11.4.4. Pharmaceutical & Biotechnology Companies
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Type
11.7.1. PCR Assays
11.7.2. Nucleic Acid Detection Kits
11.7.3. Stains
11.7.4. Elimination Kits
11.7.5. Standards & Controls
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Mycoplasma Testing Kits & Reagents Demand Share, 2019-2026
12. Asia Pacific Mycoplasma Testing Kits & Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Application
12.4.1. Academic Research Institutes
12.4.2. Cell Banks
12.4.3. Contract Research Organizations
12.4.4. Pharmaceutical & Biotechnology Companies
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Type
12.7.1. PCR Assays
12.7.2. Nucleic Acid Detection Kits
12.7.3. Stains
12.7.4. Elimination Kits
12.7.5. Standards & Controls
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Mycoplasma Testing Kits & Reagents Demand Share, 2019-2026
13. Middle East & Africa Mycoplasma Testing Kits & Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Application
13.4.1. Academic Research Institutes
13.4.2. Cell Banks
13.4.3. Contract Research Organizations
13.4.4. Pharmaceutical & Biotechnology Companies
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Mycoplasma Testing Kits & Reagents Market Size and Volume Forecast by Type
13.7.1. PCR Assays
13.7.2. Nucleic Acid Detection Kits
13.7.3. Stains
13.7.4. Elimination Kits
13.7.5. Standards & Controls
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Mycoplasma Testing Kits & Reagents Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Mycoplasma Testing Kits & Reagents Market: Market Share Analysis
14.2. Mycoplasma Testing Kits & Reagents Distributors and Customers
14.3. Mycoplasma Testing Kits & Reagents Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Thermo Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck KGaA
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Lonza Group Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. PromoCell GmbH
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ATCC (American Type Culture Collection)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Charles River Laboratories International, Inc.
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bionique Testing Laboratories, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Biological Industries Israel Beit Haemek Ltd.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. InvivoGen
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook<
